Crinetics' Chief Development and Operating Officer resigns effective April 10, 2026

Crinetics Pharmaceuticals, Inc.

Jeff Knight resigns as Chief Development and Operating Officer, effective April 10, 2026.
Resignation is to pursue another opportunity; not related to any disagreement with the Company.
No successor named; Knight's duties and direct reports reassigned to other executive leadership team members.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.